首页 馆藏资源 舆情信息 标准服务 科研活动 关于我们
现行 ISO 10993-17:2023
到馆阅读
收藏跟踪
购买正版
Biological evaluation of medical devices — Part 17: Toxicological risk assessment of medical device constituents 医疗器械生物学评价第17部分:医疗器械成分的毒理学风险评估
发布日期: 2023-09-13
本文件规定了医疗器械成分毒理学风险评估的流程和要求。还规定了用于评估暴露于成分是否没有明显危害的方法和标准。毒理学风险评估可以是最终产品生物学评价的一部分,如ISO 10993-1所述。 本文件中描述的过程适用于根据ISO?10993-18.当需要对成分信息或分析化学数据(例如可提取数据或可沥滤数据)进行毒理学风险评估以确定与成分相关的毒理学风险是可忽略的还是可耐受的时。 本文件中描述的工艺不适用于已通过其他方法估计毒理学风险的情况,例如:—?医疗器械中存在或从医疗器械中提取的成分(不包括关注队列或排除的化学品),其含量代表患者暴露量低于相关的基于毒理学的报告阈值(参见ISO?10993-18:20 20,附件?E和ISO/TS?21726中的适用要求); —?已确定与现有生物相容性或临床确定的医疗器械具有化学或生物学等效性的新的或变更的医疗器械(参见ISO?10993-18:20 20,附件?C)中的适用要求。 本文件中描述的过程也不适用于: —?不接触身体的医疗器械成分(例如体外诊断); —?与医疗器械与身体的物理相互作用(即施加机械力、能量或表面形态等)相关的生物风险。),前提是化学暴露不变; —?器械—药物组合产品的活性药物成分或器械—生物组合产品的生物成分可作为额外的监管考虑因素; —?暴露于器械以外来源(如食物、水或空气)产生的特定成分。

This document specifies the process and requirements for the toxicological risk assessment of medical device constituents. The methods and criteria used to assess whether exposure to a constituent is without appreciable harm are also specified. The toxicological risk assessment can be part of the biological evaluation of the final product, as described in ISO 10993-1.

The process described in this document applies to chemical characterization information obtained in line with ISO10993-18. When a toxicological risk assessment of either the compositional information or analytical chemistry data (e.g. extractable data or leachable data) are required to determine whether the toxicological risks related to the constituents are negligible or tolerable.

The process described in this document is not intended to apply to circumstances where the toxicological risk has been estimated by other means, such as:

constituents, excluding cohort of concern or excluded chemicals, that are present in or extracted from a medical device at an amount representative of patient exposure below a relevant, toxicologically-based reporting threshold (see applicable requirements in ISO10993-18:2020, Annex?E and ISO/TS21726);

a new or changed medical device for which chemical or biological equivalence has been established with an existing biocompatible or clinically established medical device (see applicable requirements in ISO10993-18:2020, Annex?C).

The process described in this document is also not applicable to:

medical device constituents that do not contact the body (e.g. in vitro diagnostics);

biological risks associated with physical interactions of the medical device with the body (i.e. application of mechanical forces, energy or surface morphology, etc.), provided that the chemical exposure is not changed;

active pharmaceutical ingredients of device-drug combination products or biologic components of device-biologic combination products as additional regulatory considerations can apply;

exposure to a particular constituent that arises from sources other than the device, such as food, water or air.

分类信息
发布单位或类别: 国际组织-国际标准化组织
关联关系
研制信息
归口单位: ISO/TC 194
相似标准/计划/法规
现行
DIN EN ISO 10993-17-DRAFT
Draft Document - Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/DIS 10993-17:2021); German and English version prEN ISO 10993-17:2021
文件草案医疗器械的生物学评价第17部分:医疗器械成分的毒理学风险评估;德文和英文版本prEN ISO 10993-17:2021
2021-12-01
现行
GOST ISO 10993-1-2021
Изделия медицинские. Оценка биологического действия медицинских изделий. Часть 1. Оценка и исследования в процессе менеджмента риска
医疗设备 医疗器械的生物学评价 第一部分 风险管理过程中的评估和测试
现行
GOST ISO 10993-17-2011
Изделия медицинские. Оценка биологического действия медицинских изделий. Часть 17. Установление пороговых значений для вымываемых веществ
医疗设备 医疗器械生物学评价 第17部分建立可浸出物质的允许限度
2011-11-29
现行
GB/T 16886.1-2022
医疗器械生物学评价 第1部分:风险管理过程中的评价与试验
Biological evaluation of medical devices—Part 1:Evaluation and testing within a risk management process
2022-04-15
现行
KS P ISO 10993-1
의료기기의 생물학적 평가 —제1부: 위험 관리 과정에서의 평가와 시험
医疗器械的生物学评估 - 第1部分:评估和测试
2020-12-30
现行
AAMI/ISO 10993-1-2018
Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
医疗器械的生物学评价.第1部分:风险管理过程中的评价和试验
2020-04-27
现行
ISO 10993-1-2018
Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
医疗器械的生物学评价.第1部分:风险管理过程中的评价和试验
2018-08-17
现行
KS P ISO 10993-17
의료 기기의 생물학적 평가-제17부: 용출 물질에 대한 허용 기준의 설정
医疗器械的生物学评估 - 第17部分:建立可浸出物质的允许限度
2017-12-29
现行
GB/T 16886.17-2005
医疗器械生物学评价 第17部分:可沥滤物允许限量的建立
Biological evaluation of medical devices—Part 17:Establishment of allowable limits for leachable substances
2005-11-04
现行
KS P ISO 10993-17(2022 Confirm)
의료 기기의 생물학적 평가-제17부: 용출 물질에 대한 허용 기준의 설정
医疗器械的生物评价.第17部分:可浸出物质允许限值的确定
2017-12-29
现行
ISO 10993-18-2020
Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process
医疗器械生物学评价第18部分:风险管理过程中医疗器械材料的化学特性
2020-01-13
现行
GB/T 16886.18-2022
医疗器械生物学评价 第18部分:风险管理过程中医疗器械材料的化学表征
Biological evaluation of medical devices—Part 18:Chemical characterization of medical device materials within a risk management process
2022-12-30
现行
KS P ISO 10993-18
의료기기의 생물학적 평가 —제18부: 위험 관리 과정에서의 의료기기 원자재의 화학적 특성화
医疗器械的生物学评价.第18部分:风险管理过程中医疗器械材料的化学特性
2021-12-28
现行
AAMI/ISO 10993-17-2002/(R)2012
Biological evaluation of medical devices - Part 17: Methods for the establishment of allowable limits for leachable substances
医疗器械的生物学评价.第17部分:可浸出物质允许限值的确定方法
2008-12-03
现行
UNE-EN ISO 10993-17-2009
Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances (ISO 10993-17:2002)
医疗器械的生物评定第17部分:可浸出物质允许限值的确定
2009-09-09
现行
UNE-EN ISO 10993-1-2010
Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2009)
医疗器械的生物学评价第1部分:风险管理过程中的评价和试验
2010-04-07
现行
YY/T 0127.17-2014
口腔医疗器械生物学评价 第17部分:小鼠淋巴瘤细胞(TK)基因突变试验
Biological evaluation of medical devices used in dentistry—Part 17:Mouse lymphoma cells(TK)gene mutation test
2014-06-17
现行
ISO 10993-18-2020/Amd 1-2022
Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process — Amendment 1: Determination of the uncertainty factor
医疗器械的生物学评价.第18部分:风险管理过程中医疗器械材料的化学特性.修改件1:不确定因素的测定
2022-05-11